Panacea Life Sciences PLSH Stock
Panacea Life Sciences Price Chart
Panacea Life Sciences PLSH Financial and Trading Overview
| Panacea Life Sciences stock price | 0.18 USD |
| Previous Close | 0.2 USD |
| Open | 0.21 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.19 - 0.21 USD |
| 52 Week Range | 0.04 - 0.63 USD |
| Volume | 2.1K USD |
| Avg. Volume | 14.23K USD |
| Market Cap | 3.71M USD |
| Beta (5Y Monthly) | 3.846896 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.48 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PLSH Valuation Measures
| Enterprise Value | 22.76M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.0963159 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 12.876 |
| Enterprise Value/EBITDA | -6.692 |
Trading Information
Panacea Life Sciences Stock Price History
| Beta (5Y Monthly) | 3.846896 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.63 USD |
| 52 Week Low | 0.04 USD |
| 50-Day Moving Average | 0.24 USD |
| 200-Day Moving Average | 0.28 USD |
PLSH Share Statistics
| Avg. Volume (3 month) | 14.23K USD |
| Avg. Daily Volume (10-Days) | 1.53K USD |
| Shares Outstanding | 17.65M |
| Float | 8.39M |
| Short Ratio | N/A |
| % Held by Insiders | 112.89% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -290.12% |
| Gross Margin | -243.69% |
| EBITDA Margin | -192.41% |
Management Effectiveness
| Return on Assets (ttm) | -16.098% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.77M USD |
| Revenue Per Share (ttm) | 0.11 USD |
| Quarterly Revenue Growth (yoy) | -15.00000000000000000000000000000000% |
| Gross Profit (ttm) | N/A |
| EBITDA | -3401242 USD |
| Net Income Avi to Common (ttm) | -8054074 USD |
| Diluted EPS (ttm) | -0.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 468.58K USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 19.74M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.337 |
| Book Value Per Share (mrq) | -0.316 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2031246 USD |
| Levered Free Cash Flow (ttm) | -915722 USD |
Profile of Panacea Life Sciences
| Country | United States |
| State | CO |
| City | Greenwood Village |
| Address | 5910 South University Boulevard |
| ZIP | 80121 |
| Phone | 800 985 0515 |
| Website | https://www.panacealife.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
Panacea Life Sciences Holdings, Inc., operates as a holding company, manufactures, research, and produces hemp-derived cannabinoid, functional mushroom, kratom, and nutraceutical products for consumers and pets. The company also involved in the white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. In addition, it offers natural remedies for aspect of life under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand name. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.
Q&A For Panacea Life Sciences Stock
What is a current PLSH stock price?
Panacea Life Sciences PLSH stock price today per share is 0.18 USD.
How to purchase Panacea Life Sciences stock?
You can buy PLSH shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Panacea Life Sciences?
The stock symbol or ticker of Panacea Life Sciences is PLSH.
Which industry does the Panacea Life Sciences company belong to?
The Panacea Life Sciences industry is Drug Manufacturers-Specialty & Generic.
How many shares does Panacea Life Sciences have in circulation?
The max supply of Panacea Life Sciences shares is 17.65M.
What is Panacea Life Sciences Price to Earnings Ratio (PE Ratio)?
Panacea Life Sciences PE Ratio is now.
What was Panacea Life Sciences earnings per share over the trailing 12 months (TTM)?
Panacea Life Sciences EPS is -0.48 USD over the trailing 12 months.
Which sector does the Panacea Life Sciences company belong to?
The Panacea Life Sciences sector is Healthcare.